tirzepatide surmount-1 percent weight loss 72 weeks for Obesity: Highlights from the Trial Semaglutide vs. Tirzepatide for Obesity
Description
Review dose and timing with your clinician
2020;8:p
Side effects are generally milder than tesamorelin some users experience mild water retention, occasional wrist/hand numbness, or post-injection flushing, but these tend to be less pronounced
Precision tracking for your journey Join thousands using Shotlee to accurately track GLP-1 medications and side effects
Cortisol and adrenaline lower sensory thresholds, making already-sensitive skin feel even more reactive
Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: The SURMOUNT-4 randomized clinical trial
